Simcere Zaiming

Haikou, China · Founded 2020 · In IPO Registration

Developer and manufacturer of innovative oncology drugs designed for treating cancer patients with unmet clinical needs. Simcere Zaiming is based in Haikou, China and was founded in 2020. Its last reported valuation was $1.2 billion in Jun 2025. It has raised $148 million.

Last reported valuation
$1.2B
Oct 2026
Priced at
—
Total raised
$148.4M
Last round
—
No prints on record

No secondary trades in Simcere Zaiming shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Simcere Zaiming with a free account
  • ·Watch Simcere Zaiming: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Simcere Zaiming prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Simcere Zaiming stock.